Q2 2017 Holdings
Filed 2017-08-02 | 5 holdings | $283.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $143.3K | 12,682,876 | 50.5% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $77.3K | 4,806,656 | 27.3% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $56.7K | 3,376,184 | 20.0% |
| T2 Biosystems Inc | COM | 89853L104 | $6.3K | 1,950,583 | 2.2% |